Regulation of cytochrome p450 by inflammatory mediators: why and how?
about
Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implicationsPharmacokinetic drug interactions in liver disease: An updateAdministration of a CXCL12 Analog in Endotoxemia Is Associated with Anti-Inflammatory, Anti-Oxidative and Cytoprotective Effects In VivoTherapeutic benefits of budesonide in gastroenterologyActivation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolismCytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammationCytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics studyVirtual Experiments Enable Exploring and Challenging Explanatory Mechanisms of Immune-Mediated P450 Down-RegulationRole of PXR in Hepatic Cancer: Its Influences on Liver Detoxification Capacity and Cancer ProgressionAssessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative ColitisThe cytochrome P450 genes of channel catfish: their involvement in disease defense responses as revealed by meta-analysis of RNA-Seq data sets.Variability in drug metabolizing enzyme activity in HIV-infected patients.Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria modelsTime course of gene expression profiling in the liver of experimental mice infected with Echinococcus multilocularisPregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes.Genome analysis of cytochrome P450s and their expression profiles in insecticide resistant mosquitoes, Culex quinquefasciatus.Persistent oxytetracycline exposure induces an inflammatory process that improves regenerative capacity in zebrafish larvae.A clinical therapeutic protein drug-drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis.The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.Altered CYP2C9 activity following modulation of CYP3A4 levels in human hepatocytes: an example of protein-protein interactions.Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice.The transcriptome profile of the mosquito Culex quinquefasciatus following permethrin selection.Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidneyToxicity and recovery in the pregnant mouse after gestational exposure to the cyanobacterial toxin, cylindrospermopsinMutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammationDownregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.A whole transcriptomal linkage analysis of gene co-regulation in insecticide resistant house flies, Musca domestica.Susceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice.Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.Induction of nitric oxide production mediated by tumor necrosis factor alpha on staphylococcal enterotoxin C-stimulated bovine mammary gland cells.Regulation of cytochrome P450 4F11 by nuclear transcription factor-κB.Genomic Analysis of Detoxification Supergene Families in the Mosquito Anopheles sinensisQuantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation.Dynamics of hepatic gene expression profile in a rat cecal ligation and puncture modelEnhanced oxidative stress by alcohol use in HIV+ patients: possible involvement of cytochrome P450 2E1 and antioxidant enzymes.Functional polymorphisms in CYP2C19 & CYP3A5 genes associated with decreased susceptibility for paediatric tuberculosis.Organotypic liver culture models: meeting current challenges in toxicity testing.Roles of nitric oxide in inflammatory downregulation of human cytochromes P450.Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations.
P2860
Q23923547-3D471093-4E5C-4418-9297-B1D79D283E17Q26774479-E17BEC64-DF79-47D7-B0B7-41F71B1C8A03Q27317106-FD5405DE-A2C3-463D-AAC4-AABDB6D7E75BQ28281682-D7E76E43-0566-4CBF-B774-2C674C2CCB40Q28385509-C9E09A88-40F5-499C-A6CD-32135C529FD3Q28393303-F3783742-F0E5-4012-BD5B-FE9A54F3918DQ28397330-2F279D1D-483C-4E11-A3A0-1978B8DFC7E3Q28552467-64482164-B158-4307-B370-50C61886C389Q28552770-1AAD83D8-5C21-447E-8793-932281F97D23Q28597396-32705511-389D-4EC9-9897-A3B1DCDD5666Q30811241-B8F39370-D27A-46E7-A09D-7C4A90DDDAB5Q33791508-658E8BDF-8EA6-4DCE-B222-E62AC2B499EFQ33804837-48A7A884-87B9-4E58-B344-93023C189A01Q33809462-57483FA3-11ED-42ED-ACF8-4AF9489EC020Q34101899-8E8C38E5-0E12-4821-BD7E-582D96E41973Q34126448-A7077244-1E85-4049-8235-18B5B1D3F985Q34271047-088218B2-D269-4201-A837-63674E9438E5Q34286862-815A7AD8-83B3-45F7-ABCE-30A227CC368EQ34332185-264409D6-C55D-4E95-AC3C-DD3CC368F4EAQ34360051-866D50B8-7CCD-4DF9-9A4C-20DB1C602A82Q34405854-66E72B03-FC1C-4387-BC8D-6527E6E836A8Q34448000-91DD57DD-2A84-41E2-999F-96210BCBDA72Q34452293-072DBC54-02E0-42CC-9678-88F3E5A97DBFQ34490221-BC689C80-71F2-4FB1-A162-6078C8CA847CQ34768240-74C9317F-2836-4257-B15E-B96D898C95DDQ35045258-D61A07FA-5FF9-4AFD-96F0-CD979AF30F85Q35046882-E59BCEEC-0148-4398-BE3C-D7741F1F3C6FQ35080126-EB8B397E-A9CC-4BD6-9078-112BCCFA856CQ35264808-C13F87BA-5255-4856-A4D7-E94F4F5F6C60Q35541727-05D49C37-2177-46E6-893D-C8E0A0B17736Q35647169-FEF90750-3567-45E5-A93A-D0277FA4EA27Q35847304-8F48E36C-A326-4661-88CA-9BEAFB088862Q35897768-0AA47C71-9732-4601-B96A-B4093D83D273Q36010575-10E71751-7363-4C9B-AC98-21C03D39ACFEQ36082719-968E56DB-5D3F-4521-BB65-CDC83696327FQ36107627-7CF6FB63-623B-4B54-840A-EC25817B1DF3Q36178225-74678070-2DF6-4E6C-BCC7-F97707BA1E5BQ36593723-0FBC0BD2-5A32-4B4A-9AD3-B1783EF353ECQ36608759-4AE4B1F9-0655-47EF-95FA-23BE44E9AEBFQ36887922-1B3D8C97-CDA8-43B3-92EF-6624BB312B08
P2860
Regulation of cytochrome p450 by inflammatory mediators: why and how?
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Regulation of cytochrome p450 by inflammatory mediators: why and how?
@ast
Regulation of cytochrome p450 by inflammatory mediators: why and how?
@en
type
label
Regulation of cytochrome p450 by inflammatory mediators: why and how?
@ast
Regulation of cytochrome p450 by inflammatory mediators: why and how?
@en
prefLabel
Regulation of cytochrome p450 by inflammatory mediators: why and how?
@ast
Regulation of cytochrome p450 by inflammatory mediators: why and how?
@en
P1476
Regulation of cytochrome p450 by inflammatory mediators: why and how?
@en
P2093
P304
P577
2001-03-01T00:00:00Z